Effects of ketamine-induced psychopathological symptoms on continuous overt rhyme fluency

European Archives of Psychiatry and Clinical Neuroscience

Volumn 262, Issue 5, 2012, Pages 403-414

  Nagels, Arne ^a   Kirner Veselinovic, André ^b   Wiese, Richard ^a   Paulus, Frieder M ^a   Kircher, Tilo ^a   Krach, Sören ^a  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

^b RWTH AACHEN UNIVERSITY   (Germany)

Author keywords

FMRI; Glutamate; Ketamine; N methyl D aspartate receptor; Schizophrenia; Speech production

Indexed keywords

KETAMINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR;

ADULT; ANTERIOR CINGULATE; ARTICLE; BEHAVIORAL RESEARCH; COGNITIVE DEFECT; CONTROLLED STUDY; CONVERSATION; CORRELATION ANALYSIS; FRONTAL LOBE; HUMAN; INFERIOR FRONTAL GYRUS; LANGUAGE; MENTAL DISEASE; POSITIVE AND NEGATIVE SYNDROME SCALE; PRECUNEUS; PRIORITY JOURNAL; SCHIZOPHRENIA; SCORING SYSTEM; SUPERIOR TEMPORAL GYRUS; THINKING; VERBAL BEHAVIOR; WORD RECOGNITION;

ADULT; BRAIN; BRAIN MAPPING; COGNITION DISORDERS; DOUBLE-BLIND METHOD; EXCITATORY AMINO ACID ANTAGONISTS; FUNCTIONAL LATERALITY; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; KETAMINE; MAGNETIC RESONANCE IMAGING; MALE; MENTAL DISORDERS; OXYGEN; PHOTIC STIMULATION; PSYCHIATRIC STATUS RATING SCALES; VERBAL BEHAVIOR; VOCABULARY;

EID: 84864997480     PISSN: 09401334     EISSN: 14338491     Source Type: Journal    
DOI: 10.1007/s00406-011-0281-8     Document Type: Article

References (70)

1. Abel KM, Allin MP, Kucharska-Pietura K, Andrew C, Williams S, David AS, Phillips ML (2003) Ketamine and fMRI bold signal: distinguishing between effects mediated by change in blood flow versus change in cognitive state. Hum Brain Mapp 18:135-145 (Pubitemid 36150933)
2. Abel KM, Allin MP, Kucharska-Pietura K, David A, Andrew C, Williams S, Brammer MJ, Phillips ML (2003) Ketamine alters neural processing of facial emotion recognition in healthy men: an fMRI study. Neuroreport 14:387-391 (Pubitemid 36337936)
3. Abi-Saab WM, D'Souza DC, Moghaddam B, Krystal JH (1998) The NMDA antagonist model for schizophrenia: promise and pitfalls. Pharmacopsychiatry 31(Suppl 2):104-109 (Pubitemid 28396279)
4. Adler CM, Goldberg TE, Malhotra AK, Pickar D, Breier A (1998) Effects of ketamine on thought disorder, working memory, and semanticmemory in healthy volunteers. Biol Psychiatry 43:811-816 (Pubitemid 28288379)
5. Adler CM, Malhotra AK, Elman I, Goldberg T, Egan M, Pickar D, Breier A (1999) Comparison of ketamine-induced thought disorder in healthy volunteers and thought disorder in schizophrenia. Am J Psychiatry 156:1646-1649 (Pubitemid 29460002)
6. Amann LC, Gandal MJ, Halene TB, Ehrlichman RS, White SL, McCarren HS, Siegel SJ (2010) Mouse behavioral endophenotypes for schizophrenia. Brain Res Bull 83:147-161
7. Andreasen NC (1986) Scale for the assessment of thought, language, and communication (TLC). Schizophr Bull 12:473-482
8. Assaf M, Rivkin PR, Kuzu CH, Calhoun VD, Kraut MA, Groth KM, Yassa MA, Hart J Jr, Pearlson GD (2006) Abnormal object recall and anterior cingulate overactivation correlate with formal thought disorder in schizophrenia. Biol Psychiatry 59:452-459 (Pubitemid 43289226)
9. Barbalat G, Chambon V, Franck N, Koechlin E, Farrer C (2009) Organization of cognitive control within the lateral prefrontal cortex in schizophrenia. Arch Gen Psychiatry 66:377-386
10. Bengtsson SL, Haynes JD, Sakai K, Buckley MJ, Passingham RE (2009) The representation of abstract task rules in the human prefrontal cortex. Cereb Cortex 19:1929-1936
11. Braver TS, Bongiolatti SR (2002) The role of frontopolar cortex in subgoal processing during working memory. Neuroimage 15:523-536 (Pubitemid 34852520)
12. Breier A, Malhotra AK, Pinals DA, Weisenfeld NI, Pickar D (1997) Association of ketamine-induced psychosis with focal activation of the prefrontal cortex in healthy volunteers. Am J Psychiatry 154:805-811 (Pubitemid 27230103)
13. Chatterjee M, Ganguly S, Srivastava M, Palit G (2011) Effect of 'chronic' versus 'acute' ketamine administration and its 'withdrawal' effect on behavioural alterations in mice: implications for experimental psychosis. Behav Brain Res 216:247-254
14. Chin CL, Upadhyay J, Marek GJ, Baker SJ, Zhang M, Mezler M, Fox GB, Day M (2011) Awake rat pharmacological magnetic resonance imaging as a translational pharmacodynamic biomarker: metabotropic glutamate 2/3 agonist modulation of ketamine- induced blood oxygenation level dependence signals. J Pharmacol Exp Ther 336:709-715
15. Corlett PR, Honey GD, Aitken MR, Dickinson A, Shanks DR, Absalom AR, Lee M, Pomarol-Clotet E, Murray GK, McKenna PJ, Robbins TW, Bullmore ET, Fletcher PC (2006) Frontal responses during learning predict vulnerability to the psychotogenic effects of ketamine: linking cognition, brain activity, and psychosis. Arch Gen Psychiatry 63:611-621 (Pubitemid 43848292)
16. Costafreda SG, Fu CH, Picchioni M, Toulopoulou T, McDonald C, Kravariti E, Walshe M, Prata D, Murray RM, McGuire PK (2011) Pattern of neural responses to verbal fluency shows diagnostic specificity for schizophrenia and bipolar disorder. BMC Psychiatry 11:18
17. Covington MA, Riedel WJ, Brown C, He C, Morris E, Weinstein S, Semple J, Brown J (2007) Does ketamine mimic aspects of schizophrenic speech? J Psychopharmacol 21:338-346 (Pubitemid 46934049)
18. Daumann J, Heekeren K, Neukirch A, Thiel CM, Moller-Hartmann W, Gouzoulis-Mayfrank E (2008) Pharmacological modulation of the neural basis underlying inhibition of return (IOR) in the human 5-HT 2A agonist and NMDA antagonist model of psychosis. Psychopharmacology (Berl) 200:573-583
19. Daumann J, Wagner D, Heekeren K, Neukirch A, Thiel CM, Gouzoulis-Mayfrank E (2010) Neuronal correlates of visual and auditory alertness in the DMT and ketamine model of psychosis. J Psychopharmacol 24(10):1515-1524
20. Davies BM, Beech HR (1960) The effect of 1-arylcylohexylamine (sernyl) on twelve normal volunteers. J Ment Sci 106:912-924
21. Deakin JF, Lees J, McKie S, Hallak JE, Williams SR, Dursun SM (2008) Glutamate and the neural basis of the subjective effects of ketamine: a pharmaco-magnetic resonance imaging study. Arch Gen Psychiatry 65:154-164 (Pubitemid 351214314)
22. Fijal K, Popik P (2011) Phencyclidine disturbs relational memory in the transitive inference task. Behav Pharmacol 22:262-265
23. Fu CH, Abel KM, Allin MP, Gasston D, Costafreda SG, Suckling J, Williams SC, McGuire PK (2005) Effects of ketamine on prefrontal and striatal regions in an overt verbal fluency task: a functional magnetic resonance imaging study. Psychopharmacology (Berl) 183:92-102 (Pubitemid 41484186)
24. Fu CH, Suckling J, Williams SC, Andrew CM, Vythelingum GN, McGuire PK (2005) Effects of psychotic state and task demand on prefrontal function in schizophrenia: an fMRI study of overt verbal fluency. Am J Psychiatry 162:485-494 (Pubitemid 40343915)
25. Holcomb HH, Lahti AC, Medoff DR, Cullen T, Tamminga CA (2005) Effects of noncompetitive NMDA receptor blockade on anterior cingulate cerebral blood flow in volunteers with schizophrenia. Neuropsychopharmacology 30:2275-2282 (Pubitemid 41643980)
26. Holcomb HH, Lahti AC, Medoff DR, Weiler M, Tamminga CA (2001) Sequential regional cerebral blood flow brain scans usingPET with H2(15)O demonstrate ketamine actions in CNS dynamically. Neuropsychopharmacology 25:165-172 (Pubitemid 32566338)
27. Honey GD, Corlett PR, Absalom AR, Lee M, Pomarol-Clotet E, Murray GK, McKenna PJ, Bullmore ET, Menon DK, Fletcher PC (2008) Individual differences in psychotic effects of ketamine are predicted by brain function measured under placebo. J Neurosci 28:6295-6303
28. Honey GD, Honey RA, O'Loughlin C, Sharar SR, Kumaran D, Suckling J, Menon DK, Sleator C, Bullmore ET, Fletcher PC (2005) Ketamine disrupts frontal and hippocampal contribution to encoding and retrieval of episodic memory: an fMRI study. Cereb Cortex 15:749-759 (Pubitemid 40703969)
29. Honey RA, Honey GD, O'Loughlin C, Sharar SR, Kumaran D, Bullmore ET, Menon DK, Donovan T, Lupson VC, Bisbrown- Chippendale R, Fletcher PC (2004) Acute ketamine administration alters the brain responses to executive demands in a verbal working memory task: an fMRI study. Neuropsychopharmacology 29:1203-1214 (Pubitemid 38670056)
30. Javitt DC, Zukin SR (1991) Recent advances in the phencyclidine model of schizophrenia. Am J Psychiatry 148:1301-1308
31. Kay SR, Fiszbein A, Opler LA (1987) The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull 13:261-276 (Pubitemid 18039085)
32. Kircher T, Bullmore ET, Brammer M, Broome M, Williams S, Murray R, McGuire P (2001) Differential activation of temporal cortex during sentence completion in schizophrenic patients with and without formal thought disorder. Schizophr Res 50:27-40 (Pubitemid 32510885)
33. Kircher T, Liddle P, Brammer M, Murray R, McGuire P (2003) Neuronale korrelate "negativer" formaler Denkstörungen. Nervenarzt 74:748-754 (Pubitemid 37176304)
34. Kircher T, Nagels A, Kirner-Veselinovic A, Krach S (2011) Neural correlates of rhyming vs. lexical and semantic fluency. Brain Res 1391:71-80
35. Kircher TT, Leube DT, Erb M, Grodd W, Rapp AM (2007) Neural correlates of metaphor processing in schizophrenia. Neuroimage 34:281-289 (Pubitemid 44765253)
36. Kircher TT, Liddle PF, Brammer MJ, Williams SC, Murray RM, McGuire PK (2001) Neural correlates of formal thought disorder in schizophrenia: preliminary findings from a functional magnetic resonance imaging study. Arch Gen Psychiatry 58:769-774 (Pubitemid 32717801)
37. Krach S, Hartje W (2006) Comparison of hemispheric activation during mental word and rhyme generation using transcranial Doppler sonography. Brain Lang 96:269-279 (Pubitemid 43339827)
38. Krystal JH, D'Souza DC, Mathalon D, Perry E, Belger A, Hoffman R (2003) Nmda receptor antagonist effects, cortical glutamatergic function, and schizophrenia: Toward a paradigm shift in medication development. Psychopharmacology (Berl) 169:215-233 (Pubitemid 37264943)
39. Krystal JH, Karper LP, Bennett A, D'Souza DC, Abi-Dargham A, Morrissey K, Abi-Saab D, Bremner JD, Bowers MB Jr, Suckow RF, Stetson P, Heninger GR, Charney DS (1998) Interactive effects of subanesthetic ketamine and subhypnotic lorazepam in humans. Psychopharmacology (Berl) 135:213-229 (Pubitemid 28055456)
40. Krystal JH, Karper LP, Seibyl JP, Freeman GK, Delaney R, Bremner JD, Heninger GR, Bowers MB Jr, Charney DS (1994) Subanesthetic effects of the noncompetitive nmda antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses. Arch Gen Psychiatry 51:199-214 (Pubitemid 24081509)
41. Krystal JH, Perry EB Jr, Gueorguieva R, Belger A, Madonick SH, Abi-Dargham A, Cooper TB, Macdougall L, Abi-Saab W, D'Souza DC (2005) Comparative and interactive human psychopharmacologic effects of ketamine and amphetamine: implications for glutamatergic and dopaminergic model psychoses and cognitive function. Arch Gen Psychiatry 62:985-994
42. Lahti AC, Holcomb HH, Medoff DR, Tamminga CA (1995) Ketamine activates psychosis and alters limbic blood flow in schizophrenia. Neuroreport 6:869-872
43. Leube D, Whitney C, Kircher T (2008) The neural correlates of ego-disturbances (passivity phenomena) and formal thought disorder in schizophrenia. Eur Arch Psychiatry Clin Neurosci 258(Suppl 5):22-27
44. Lorrain DS, Baccei CS, Bristow LJ, Anderson JJ, Varney MA (2003) Effects of ketamine and N-methyl-D-aspartate on glutamate and dopamine release in the rat prefrontal cortex: modulation by a group ii selective metabotropic glutamate receptor agonist LY379268. Neuroscience 117:697-706 (Pubitemid 36263162)
45. Luby ED, Cohen BD, Rosenbaum G, Gottlieb JS, Kelley R (1959) Study of a new schizophrenomimetic drug; sernyl. AMA Arch Neurol Psychiatry 81:363-369
46. Malhotra AK, Pinals DA, Adler CM, Elman I, Clifton A, Pickar D, Breier A (1997) Ketamine-induced exacerbation of psychotic symptoms and cognitive impairment in neuroleptic-free schizophrenics. Neuropsychopharmacology 17:141-150 (Pubitemid 27365955)
47. Malhotra AK, Pinals DA, Weingartner H, Sirocco K, Missar CD, Pickar D, Breier A (1996) NMDA receptor function and human cognition: the effects of ketamine in healthy volunteers. Neuropsychopharmacology 14:301-307 (Pubitemid 26151927)
48. McKenna PJ, Oh TM (2005) Schizophrenic speech: making sense of bathroots and ponds that fall in doorways. Cambridge University Press, Cambridge
49. Moghaddam B, Adams B, Verma A, Daly D (1997) Activation of glutamatergic neurotransmission by ketamine: a novel step in the pathway from NMDA receptor blockade to dopaminergic and cognitive disruptions associated with the prefrontal cortex. J Neurosci 17:2921-2927 (Pubitemid 27155025)
50. Morgan CJ, Mofeez A, Brandner B, Bromley L, Curran HV (2004) Acute effects of ketamine on memory systems and psychotic symptoms in healthy volunteers. Neuropsychopharmacology 29:208-218 (Pubitemid 38068031)
51. Musso F, Brinkmeyer J, Ecker D, London MK, Thieme G, Warbrick T, Wittsack HJ, Saleh A, Greb W, de Boer P, Winterer G (2011) Ketamine effects on brain function-simultaneous fMRI/ EEG during a visual oddball task. Neuroimage 58(2):508-525
52. Nagels A, Kirner-Veselinovic A, Krach S, Kircher T (2011) Neural correlates of s-ketamine induced psychosis during overt continuous verbal fluency. Neuroimage 54:1307-1314
53. Neill JC, Barnes S, Cook S, Grayson B, Idris NF, McLean SL, Snigdha S, Rajagopal L, Harte MK (2010) Animal models of cognitive dysfunction and negative symptoms of schizophrenia: focus on NMDA receptor antagonism. Pharmacol Ther 128:419-432
54. Newcomer JW, Farber NB, Jevtovic-Todorovic V, Selke G, Melson AK, Hershey T, Craft S, Olney JW (1999) Ketamineinduced NMDA receptor hypofunction as a model of memory impairment and psychosis. Neuropsychopharmacology 20:106-118 (Pubitemid 29010370)
55. Northoff G, Richter A, Bermpohl F, Grimm S, Martin E, Marcar VL, Wahl C, Hell D, Boeker H (2005) NMDA hypofunction in the posterior cingulate as a model for schizophrenia: an exploratory ketamine administration study in fMRI. Schizophr Res 72:235-248 (Pubitemid 39550994)
56. Oldfield RC (1971) The assessment and analysis of handedness: the Edinburgh inventory. Neuropsychologia 9:97-113
57. Olney JW, Labruyere J, Price MT (1989) Pathological changes induced in cerebrocortical neurons by phencyclidine and related drugs. Science 244:1360-1362 (Pubitemid 19170513)
58. Oye I, Paulsen O, Maurset A (1992) Effects of ketamine on sensory perception: evidence for a role of N-methyl-D-aspartate receptors. J Pharmacol Exp Ther 260:1209-1213
59. Rosenbaum G, Cohen BD, Luby ED, Gottlieb JS, Yelen D (1959) Comparison of sernyl with other drugs: simulation of schizophrenic performance with sernyl, Lsd-25, and amobarbital (amytal) sodium; I. Attention, motor function, and proprioception. Arch Gen Psychiatry 1:651-656
60. Rowland LM, Astur RS, Jung RE, Bustillo JR, Lauriello J, Yeo RA (2005) Selective cognitive impairments associated with NMDA receptor blockade in humans. Neuropsychopharmacology 30:633-639 (Pubitemid 40271165)
61. Sabb FW, van Erp TG, Hardt ME, Dapretto M, Caplan R, Cannon TD, Bearden CE (2010) Language network dysfunction as a predictor of outcome in youth at clinical high risk for psychosis. Schizophr Res 116:173-183
62. Shim SS, Hammonds MD, Kee BS (2008) Potentiation of the NMDA receptor in the treatment of schizophrenia: focused on the glycine site. Eur Arch Psychiatry Clin Neurosci 258:16-27
63. Slotnick SD, Moo LR, Segal JB, Hart J Jr (2003) Distinct prefrontal cortex activity associated with item memory and source memory for visual shapes. Brain Res 17:75-82 (Pubitemid 36577543)
64. Talairach J, Tournoux P (1988) Co-planar stereotaxic atlas of the human brain. Thieme, Stuttgart
65. Tamminga CA, Holcomb HH, Gao XM, Lahti AC (1995) Glutamate pharmacology and the treatment of schizophrenia: current status and future directions. Int Clin Psychopharmacol 10(Suppl 3):29-37 (Pubitemid 26054878)
66. Tan S, Rudd JA, Yew DT (2011) Gene expression changes in GABA(A) receptors and cognition following chronic ketamine administration in mice. PLoS One 6:e21328
67. Vollenweider FX (1998) Advances and pathophysiological models of hallucinogenic drug actions in humans: a preamble to schizophrenia research. Pharmacopsychiatry 31(Suppl 2):92-103 (Pubitemid 28396278)
68. Vollenweider FX, Geyer MA (2001) A systems model of altered consciousness: integrating natural and drug-induced psychoses. Brain Res Bull 56:495-507 (Pubitemid 34031785)
69. Vollenweider FX, Leenders KL, Oye I, Hell D, Angst J (1997) Differential psychopathology and patterns of cerebral glucose utilisation produced by (S)- and (R)-ketamine in healthy volunteers using positron emission tomography (PET). Eur Neuropsychopharmacol 7:25-38 (Pubitemid 27139717)
70. Vollenweider FX, Leenders KL, Scharfetter C, Antonini A, Maguire P, Missimer J, Angst J (1997) Metabolic hyperfrontality and psychopathology in the ketamine model of psychosis using positron emission tomography (PET) and [18f]fluorodeoxyglucose (FDG). Eur Neuropsychopharmacol 7:9-24. (Pubitemid 27139716)